最新报道:ProPhase Labs shares plummeted 19.43% as its crypto treasury strategy backfired, with the company now pivoting to focus on AI and biotech. The firm had allocated $10 million to Bitcoin and Ethereum in 2021, but faced significant losses amid the crypto downturn. CEO Ted Karkus acknowledged the misstep, stating the company is shifting resources to more promising sectors like AI-driven diagnostics. Despite the crypto losses, ProPhase maintains $25 million in cash reserves and continues its Nasdaq listing, with analysts divided on whether the turnaround plan can revive investor confidence.